Fate Therapeutics, Inc. (FATE)
2.435
+0.10
(+4.51%)
USD |
NASDAQ |
Aug 24, 16:00
2.435
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Total Assets (Quarterly) : 260.10M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 260.10M |
| March 31, 2026 | 284.92M |
| December 31, 2025 | 318.94M |
| September 30, 2025 | 343.67M |
| June 30, 2025 | 371.63M |
| March 31, 2025 | 398.67M |
| December 31, 2024 | 440.69M |
| September 30, 2024 | 494.97M |
| June 30, 2024 | 528.82M |
| March 31, 2024 | 569.89M |
| December 31, 2023 | 506.22M |
| September 30, 2023 | 543.79M |
| June 30, 2023 | 584.76M |
| March 31, 2023 | 630.34M |
| December 31, 2022 | 705.56M |
| September 30, 2022 | 749.35M |
| June 30, 2022 | 807.06M |
| March 31, 2022 | 858.39M |
| December 31, 2021 | 921.46M |
| September 30, 2021 | 984.57M |
| June 30, 2021 | 1.016B |
| March 31, 2021 | 1.046B |
| December 31, 2020 | 622.46M |
| September 30, 2020 | 626.44M |
| June 30, 2020 | 653.59M |
| Date | Value |
|---|---|
| March 31, 2020 | 321.89M |
| December 31, 2019 | 302.27M |
| September 30, 2019 | 340.21M |
| June 30, 2019 | 199.88M |
| March 31, 2019 | 220.86M |
| December 31, 2018 | 213.03M |
| September 30, 2018 | 219.95M |
| June 30, 2018 | 83.16M |
| March 31, 2018 | 93.42M |
| December 31, 2017 | 105.29M |
| September 30, 2017 | 72.68M |
| June 30, 2017 | 73.95M |
| March 31, 2017 | 85.33M |
| December 31, 2016 | 95.05M |
| September 30, 2016 | 49.30M |
| June 30, 2016 | 49.18M |
| March 31, 2016 | 58.70M |
| December 31, 2015 | 67.96M |
| September 30, 2015 | 76.40M |
| June 30, 2015 | 83.48M |
| March 31, 2015 | 44.49M |
| December 31, 2014 | 51.20M |
| September 30, 2014 | 47.01M |
| June 30, 2014 | 43.55M |
| March 31, 2014 | 49.65M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 106.66M |
| Shareholders Equity (Quarterly) | 153.44M |
| Debt to Equity Ratio | 0.4932 |
| Current Ratio | 4.846 |
| Net Debt Paydown Yield | 0.49% |